These lab-manufactured options were not developed with recreational use in mind. During the 1990s, John W. Huffman in addition to a team of fellow chemists at Clemson College created several of the initially formulation for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impa